Please Wait
Applying Filters...

Approved Marketing Authorisations (MA) containing Hyoscine N-Butyl Bromide in Europe. Original Data : EMA Website

Menu
$ API Ref.Price (USD/KG) : 1,346Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ALFRED E TIEFENBACHER GmbH & Co KG

02 1Boehringer Ingelheim

03 1Boehringer Ingelheim International GmbH

04 1Opella Healthcare Switzerland AG

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Regulatory Info : EU Dossier Readiness-Q1 2019

Registration Country : Germany

Butylscopolamine

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Dossier Readiness-Q1 2019

Registration Country : Germany

Tiefenbacher Compnay Banner

02

SupplySide West 2024
Not Confirmed
arrow
arrow
SupplySide West 2024
Not Confirmed

hyoscinbutylbromid

Brand Name : buscopan

Dosage Form : SOLUTION FOR INJECTION

Dosage Strength : 20 MG / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

03

SupplySide West 2024
Not Confirmed
arrow
arrow
SupplySide West 2024
Not Confirmed

Scopolamine butyl bromide

Brand Name : Buscopan

Dosage Form : Injection fluid, resolution

Dosage Strength : 20 mg/ml

Packaging : Ampoule

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

04

Opella Healthcare Switzerland AG

Country
SupplySide West 2024
Not Confirmed
arrow

Opella Healthcare Switzerland AG

Country
arrow
SupplySide West 2024
Not Confirmed

Scopolamine butyl bromide

Brand Name : Buscopan Inject

Dosage Form : Inj Sol

Dosage Strength : 20mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank